| Serial Number | 79272216 |
| Word Mark | OGAB |
| Filing Date | Thursday, August 22, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, March 2, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | ORDERED GENE ASSEMBLY IN BACILLUS SUBTILIS |
| Goods and Services | Research and development relating to DNA synthesis technology; technical advisory services and information technology consulting services relating to DNA synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; technical advisory services and information technology consulting services relating to genome synthesis technology; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection and research of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; information technology services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; testing, inspection and research relating to medical treatment or medical technology with genome synthesis technology; information technology consulting services for testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; testing, inspection or research on agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; DNA synthesis services for others for scientific research purposes; research and development services in the field of gene expression systems; research and development services in the fields of microorganisms and cells; DNA sequence design services for scientific research purposes; research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; technical research in the field of microorganisms; bacteriological research; biological research |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 22, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Synplogen Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Saturday, July 30, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, April 20, 2022 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Monday, March 21, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, March 2, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, March 2, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, February 5, 2022 | LIMITATION OF GOODS RECEIVED FROM IB |
| Monday, May 10, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, April 21, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 21, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, March 3, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, March 2, 2021 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Tuesday, March 2, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, September 18, 2020 | REFUSAL PROCESSED BY IB |
| Monday, August 17, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 17, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, August 17, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, July 16, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 16, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 10, 2020 | ASSIGNED TO LIE |
| Tuesday, June 30, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 17, 2020 | REFUSAL PROCESSED BY IB |
| Monday, December 30, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, December 30, 2019 | REFUSAL PROCESSED BY MPU |
| Wednesday, December 4, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, December 3, 2019 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 3, 2019 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 26, 2019 | APPLICATION FILING RECEIPT MAILED |
| Friday, November 22, 2019 | ASSIGNED TO EXAMINER |
| Friday, November 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, November 21, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |